Originalbeitrag in Fachzeitschrift
JAK1/2 inhibitor therapy-associated lymphomas in myelofibrosis arising from a preexisting B-cell clone
Porpaczy E, Tripolt S, Holbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, et al. JAK1/2 inhibitor therapy-associated lymphomas in myelofibrosis arising from a preexisting B-cell clone. Oncology Research and Treatment. 2018;41:38-9.
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Thomas Kolbe
ao.Univ.Prof. Dipl.-Ing.Dr. Thomas Kolbe
